ANVISA’s RDC 751: Technical Dossier Regulatory Compliance
In effect from March 1, 2023, the technical dossier must be planned as described in the Brazilian Health Regulatory Agency, or the Agência Nacional de Vigilância Sanitária (ANVISA)’s new medical device regulation, RDC 751/2022. This blog provides you with an insight on technical dossier Regulatory compliance in accordance with the new resolution.